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Using retroviral entrapment vectors, we identified a novel mouse gene whose expression is restricted to vascular endothelial
cells and their precursors in the yolk sac blood islands. A 3.68-kb cDNA corresponding to the endogenous transcript was
isolated using genomic DNA flanking the entrapment vector insertion as a probe. We have named this gene Vezf1 for
vascular endothelial zinc finger 1. Vezf1 encodes a protein with a predicted molecular mass of 56 kDa and that contains six
putative zinc finger domains and shows high homology to a previously identified human gene, DB1, that is believed to be
involved in regulating expression of cytokine genes such as interleukin-3. In situ hybridization analysis revealed the onset
of expression in advanced primitive streak-stage embryos being located in the extraembryonic mesodermal component of
the visceral yolk sac and in the anteriormost mesoderm of the embryo proper. During head-fold and somite stages,
expression was restricted to vascular endothelial cells that arise during both vasculogenesis and angiogenesis. Vezf1-related
sequences were found to be highly conserved among higher vertebrate species that have acquired extraembryonic yolk sac
membranes during evolution. The Vezf1 locus mapped to the proximal part of mouse chromosome 2, a region which has
homology to human chromosome 9q. Vezf1 expression correlates temporally and spatially with the early differentiation of
angioblasts into the endothelial cell lineage and the proliferation of endothelial cells of the embryonic vascular system.
Thus, Vezf1 may play an important role in the endothelial lineage determination and may have an additional role during
later stages of embryonic vasculogenesis and angiogenesis. © 1999 Academic PressKey Words: vasculogenesis; blood islands; angioblasts; endothelial cells; Vezf1; mouse embryogenesis; gene trap.
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The vertebrate circulatory system is derived from the
lateral plate mesoderm and the extraembryonic mesoderm
of the visceral yolk sac and consists of the heart, blood cells,
and a network of blood vessels. Classical embryological
studies in avians and recent molecular genetic studies in
the mouse have provided insights into the mechanisms
underlying embryonic blood vessel development. Develop-
ment of the vascular system involves four distinct pro-
cesses, (i) the formation of angioblasts, (ii) vasculogenesis,
(iii) angiogenesis, and (iv) assembly and stabilization of
blood vessel walls (for recent reviews, see Breier and Risau,
1996; Folkman and D’Amore, 1996; Hanahan and Folkman,
1996; Risau, 1997).
1 To whom correspondence should be addressed at the Brookdale
Center for Developmental and Molecular Biology, Box 1126,d
V
Mount Sinai School of Medicine, New York, NY 10029. Fax: (212)
860-9279. E-mail: stuhlmann@msvax.mssm.edu.
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All rights of reproduction in any form reserved.The precursors of vascular endothelial cells, the angio-
lasts, form by aggregation of mesodermal cells into angio-
enic clusters. Members of the fibroblast growth factor
amily, and possibly BMP-2/4, are required for this process
Flamme and Risau, 1992; Winnier et al., 1995). In verte-
rates with yolk, angioblasts first arise at the late primitive
treak stage in the blood islands of the visceral yolk sac.
he central cells of the blood islands differentiate into
mbryonic hematopoietic cells, whereas the peripheral
ells give rise to endothelial cells. Recent studies support
he hypothesis that both hematopoietic and endothelial
ineages in the blood islands share a bipotential precursor,
he hemangioblast (Choi et al., 1998; Kennedy et al., 1997;
halaby et al., 1995, 1997). Differentiation and growth of
he blood islands give rise to a capillary network that drains
nto the two vitelline veins of the embryo. In addition,
ntraembryonic angioblasts arise in the paraxial and lateral
esoderm of the embryo and form the endocardium, the
orsal aorta, and the large vessels of the head, lung, and gut.
asculogenesis involves the de novo differentiation of en-
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124 Xiong et al.dothelial cells from angioblasts and their assembly into
primitive blood vessels. This process is regulated by signal-
ing through a receptor tyrosine kinase pathway and in-
volves vascular endothelial growth factor (VEGF) and its
cellular receptors, VEGFR-1 or flt-1 and VEGFR-2 or flk-1
Breier et al., 1992; Breier and Risau, 1996; Carmeliet et al.,
996; Ferrara et al., 1996; Fong et al., 1995; Millauer et al.,
993; Shalaby et al., 1995, 1997; Yamaguchi et al., 1993).
Angiogenesis involves the maturation and remodeling of
he primitive vascular plexus into a complex network of
arge and small vessels. In addition, angiogenesis leads to
rowth and sprouting of preexisting vessels into inter-
omitic spaces and initially avascular organs, such as kid-
ey, brain, and limb buds (Coffin and Poole, 1991). Angio-
enesis is controlled by a second family of receptor tyrosine
inases, tie-1 and tie-2/tek, and the tie-2 ligands, Ang1 and
ng2 (Dumont et al., 1994; Maisonpierre et al., 1997; Puri
t al., 1995; Sato et al., 1995; Suri et al., 1996). Gene-
argeting studies indicated that each component of the
EGF and Ang1/Ang2 signaling pathways is essential for
ascular development and that there is no functional redun-
ancy among the ligand or its receptors. The final process of
lood vessel formation is the assembly and stabilization of
lood vessels. It involves the recruitment of mesenchymal
ells and their differentiation into pericytes and smooth
uscle cells. Several signaling pathways appear to be in-
olved in these processes, including members of the TGFb
family, their receptors, the TGFb-binding protein endoglin,
ctivin receptor-like kinase 1, and platelet-derived growth
actor receptor-b (Dickson et al., 1995; Leveen et al., 1994;
cAllister et al., 1994; Roelen et al., 1997).
While the significance of the VEGF and Ang1/Ang2
ignaling pathways for early vasculogenesis and angiogen-
sis has been recognized, little is known about the nature of
ndothelial-specific transcription factors that function up-
tream or downstream in these pathways. Through gene
argeting experiments, a role during blood vessel develop-
ent has been demonstrated for several known transcrip-
ion factors, including arylhydrocarbon-receptor nuclear
ranslocator (ARNT) (Maltepe et al., 1997), hypoxia-
nducible factor 1a (HIF1a) (Iyer et al., 1998), SCL/tal1
(Visvander et al., 1998), and LKLF (Kuo et al., 1997).
However, expression of these factors is not restricted to the
endothelial lineage, and their relationship to the vascular
signaling pathways remains largely unknown.
FIG. 1. AP reporter gene expression during in vitro differentiation
differentiate into EBs as described under Materials and Methods. A
suspension culture or from EBs that were replated for 6 days (D), sta
MZ-U stereomicroscope.
IG. 2. AP reporter gene expression in 1-13 transgenic embryos.
D-1 females. Staged embryos from E7.25 to E11.5 were isolated, fi
and 3 days. (A) Three heterozygous E7.25 embryos and one wi
ild-type littermate (left), (C) one heterozygous E8.5 embryo (left) and o
top) and one wild-type littermate (bottom), (E) one heterozygous E10.5
Copyright © 1999 by Academic Press. All rightTo identify genes involved in the development of the
circulatory system in mammals, we have performed a
genetic screen in ES cells and mouse embryos using retro-
viral entrapment vectors (Xiong et al., 1998). One ES cell
clone displayed regulated expression of the alkaline phos-
phatase (AP) reporter gene that colocalized with that of the
endothelial-specific marker flk-1 (Yamaguchi et al., 1993) in
embryoid bodies and embryos derived from this clone
(Leahy et al., 1999; Xiong et al., 1998). We report here on the
isolation and characterization of the entrapped gene, Vezf1
(vascular endothelial zinc finger 1). Its restricted expression
suggests that Vezf1 participates in the molecular pathways
that control early blood vessel development.
MATERIALS AND METHODS
Culture of ES Cells and Embryoid Bodies
ES cell clone 1-13 was identified previously in a genetic screen
using retroviral entrapment vectors (Xiong et al., 1998). Undiffer-
entiated clone 1-13 ES cells were maintained by culture in gelatin-
coated dishes on g-irradiated mouse embryonic fibroblasts as feeder
ells. Cells were induced to spontaneously differentiate into em-
ryoid bodies (EBs) by growing small aggregates of ES cells for 2
ays and transferring them into suspension culture. Aliquots of EBs
ere harvested at days 4, 7, and 10; fixed; and histochemically
tained for expression of the AP reporter gene. In parallel, day 4 EBs
ere replated on gelatin-coated tissue culture plates. Reattached
Bs, containing a variety of differentiated cell types, were fixed and
tained for AP expression 6 days later. Medium for the culture of ES
ells and EBs was as described (Xiong et al., 1998).
Generation of ES Cell Aggregation Chimeras and
Transgenic Mice
Clone 1-13 ES cells were used to generate germ-line chimeras by
employing the ES cell–diploid embryo aggregation method (Nagy
and Rossant, 1993; Xiong et al., 1998). Briefly, ES cells were
ggregated with eight-cell-stage CD-1 mouse embryos, and aggre-
ates were cultured overnight at 37°C to develop into compacted
orula or blastocysts. Aggregated embryos were reintroduced into
he uterus of day 2.5 pseudo-pregnant Swiss Webster foster females
morning of the plug counted as day 0.5) and developed to term.
himeric males with strong ES cell contribution were identified by
heir agouti coat color and eye pigmentation and were bred with
D-1 females. Agouti F1 offspring were examined for the presence
f entrapment vector DNA in their tail DNAs. Inbred mice
cell clone 1-13. Clone 1-13 ES cells were induced to spontaneously
ots were harvested from day 4 (A), day 7 (B), or day 10 EBs (C) in
for AP activity with BCIP 1 NBT, and photographed using a Nikon
s heterozygous for the 1-13 insertion were mated with wild-type
, and stained with BM Purple AP (Boehringer Mannheim) between
e littermate, (B) two heterozygous E7.5 embryos (right) and oneof ES
liqu
ined
Male
xed
ld-typ
ne wild-type littermate (right), (D) one heterozygous E9.5 embryo
embryo, (F) one heterozygous E11.5 embryo.
s of reproduction in any form reserved.
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126 Xiong et al.heterozygous and homozygous for the insertion were generated by
crossing F1 founder males with 129/Sv females or by intercrossing
of heterozygous F1 males and females. Their genotypes were
determined by Southern blot analysis of genomic DNA using a
0.9-kb KpnI–EcoRI genomic fragment that contains 1-13 flanking
DNA sequences (Fig. 4A) as a probe.
AP Staining of Whole-Mount Embryos and
Histological Sections
Staged embryos (morning of the plug counted as day 0.5) were
dissected from their deciduas of pregnant CD-1 females that were
mated with heterozygous 1-13 males. Mouse embryos and extraem-
bryonic membranes from stage E7.25 to E13.5 were fixed, heat-
treated for 30 min at 70°C, and subjected to AP staining using the
BM purple BCIP/NBT substrate (Boehringer Mannheim) and in the
presence of 0.24 mg/ml levamisole (Fields-Berry et al., 1992; Xiong
et al., 1998). Whole-mount stained embryos were embedded in
araffin, sectioned by conventional methods (Hogan et al., 1994),
nd photographed under a Nikon SMZ-U stereomicroscope or a
eiss Axioskop Microscope.
Molecular Cloning of Genomic DNA Flanking the
Retroviral Insertion and cDNA
Retroviral vector and flanking genomic DNA from ES cell clone
1-13 was cloned by supF complementation as described previously
(Xiong et al., 1998). A 0.9-kb KpnI–EcoRI fragment containing 109
bp of 39 Mo-MLV long terminal repeat sequences and about 800 bp
f 39 flanking genomic sequences was used as a probe to screen an
7.5 mouse embryonic cDNA library (provided by J. Gerhart). The
wo longest overlapping cDNAs, termed 10-1 and 10-2, were
solated, subcloned, and sequenced on both strands, using an
utomatic DNA sequencer (ABI50; Utah State University) and a
ommercial sequencing kit (Sequenase Version 2.0; USB). Sequenc-
ng homology analysis was performed using the BLAST comparison
lgorithms. Full-length coding cDNA was obtained by RT-PCR
sing total RNA from day 7 embryoid bodies. The first-strand DNA
as synthesized in a 25-ml reverse transcriptase (RT) reaction
containing 1 mg RNA, 2 pmol primer (59-TCATTGCTATATT-
GAGA-39, corresponding to nucleotides 1487–1503 in the Vezf1
cDNA), 400 mM dNTPs, 10 mM DTT, 13 first-strand buffer
(GIBCO BRL), and 200 u Superscript II (GIBCO BRL) at 42°C for 1 h.
A Vezf1-specific cDNA fragment was amplified in a 100-ml PCR
containing 5 ml of RT mixture, 20 pmol of each primer, 200 mM
NTPs, 2 u Vent polymerase (NEB), 13 Vent reaction buffer, 2 mM
gSO4. Primers used in the PCR were 59 primer (EcoRI.DB1A,
9-GGA ATT CCG GGG GGA GTG GGG AGG A-39) correspond-
ng to nucleotides 3–20 of the human DB1 cDNA (Koyano-
akagawa et al., 1994) and 39 primer (BamHI.12T7.2, 59-CGG GAT
CCC GTG ATG GTG ACA GGG TGT GCT A-39) corresponding
to nucleotides 1423–1443 in the mouse Vezf1 cDNA. PCR cycles
were 94°C for 1 min, 55°C for 1 min, 72°C for 2 min, and 35 cycles.
Vezf1-specific PCR fragments were subcloned into the pBluescript
vector and sequenced on both strands of DNA.
RNA in Situ Hybridization
Vezf1 cDNA clone 10-1 (probe C in Fig. 4B), corresponding to
nucleotide 1397 to 2899, and a Pur-1 EST clone (obtained from
Genome Systems) were used as templates for the synthesis of sense
and antisense probes by RNA in vitro transcription. The 970-base
R
3
Copyright © 1999 by Academic Press. All rightPur-1 antisense probe, corresponding to nucleotides 1429 to 2400,
was devoid of Zn finger coding sequences, and the sense probe
corresponded to nucleotides 880 to 2400. In situ hybridization to
paraffin-embedded, sectioned embryos was performed as described
previously (Leahy et al., 1999; Sassoon and Rosenthal, 1993).
RNA Isolation and Northern Hybridization
Analysis
Total RNA was prepared from tissues and cell lines by using a
modification of the guanidinium–CsCl method previously de-
scribed (Chirgwin et al., 1979). Briefly, tissues were homogenized
n ice in guanidinium buffer (4 M guanidinium thiocyanate, 25
M Na citrate, pH 7.0, 0.5% Sarcosyl, 0.1 M b-mercaptoethanol).
Cultured cells and embryoid bodies were washed in ice-cold PBS
and lysed in guanidium buffer, and the viscosity of the lysate was
reduced by shearing through a 21-gauge needle. RNA was pelleted
through a CsCl step gradient (6.2 M CsCl, 0.1 M EDTA, pH 8.0) by
centrifugation for 18 h at 35,000 rpm and 15°C. RNA pellets were
washed with 80% ethanol/TE (10 mM Tris, pH 7.5; 1 mM EDTA,
pH 8.0), dissolved in TE buffer, and precipitated by adding 0.1 vol 3
M Na acetate and 2.5 vol ethanol.
Twenty-microgram samples of RNA were electrophoresed on
1% agarose–formaldehyde gels using standard procedures. Gels
were transferred in 203 SSC to nitrocellulose membranes (Optit-
an; Schleicher & Schuell), and the filters were hybridized with 1 3
07 cpm of a random hexamer-primed, [a-32P]dCTP-labeled frag-
ent of the Vezf1 cDNA (nucleotides 3–776, probe A in Fig. 4B) at
2°C in 50% formamide. Filters were washed at 50°C in 0.23 SSPE
36 mM NaCl; 2 mM NaPO4, pH 7.7; 0.2 mM EDTA), 0.1% SDS
nd exposed for 1–2 days. To control for RNA loading, filters were
tripped and hybridized with a [a-32P]dCTP-labeled mouse GAPDH
DNA plasmid.
Southern Analysis of Genomic DNA and “Zoo
Blot” Analysis
Preparation of high-molecular-weight DNA from cultured cells
and tail biopsies and agarose gel electrophoresis were performed as
described previously (Xiong et al., 1998). For Southern analysis of
“zoo blots,” high-molecular-weight DNA was prepared from dif-
ferent vertebrate and invertebrate species. Twenty micrograms of
DNA of mouse or human DNA and equivalent amounts of DNA
from other species reflecting their genome complexity were di-
gested with BamHI, EcoRI, or HindIII, respectively. Digested DNA
was separated on 0.8% agarose gels and transferred to nitrocellu-
lose membranes (Optitran; Schleicher & Schuell). The filters were
hybridized to 2 3 107 cpm of an [a-32P]dCTP-labeled fragment of
he Vezf1 cDNA that included 3 12 of the 6 zinc fingers (nucleotides
97–1480, probe B in Fig. 4B) under reduced stringency conditions
35°C in 50% formamide, 53 SSC, 23 Denhardt’s, 0.5% SDS, 100
mg/ml denatured salmon sperm DNA). Blots were washed at
increasing stringency, with the final two washes at 65°C in 0.23
SSC, 0.1% SDS for 30 min each, and exposed for 1–4 days. After
decay of the probe, filters were rehybridized subsequently with a
59-Vezf1 probe (probe A in Fig. 4B) and a 59-Pur-1 probe [correspond-
ng to nucleotides 490–905 in the Pur-1 cDNA (Kennedy and
utter, 1992)]. Hybridization was performed in 50% formamide at
7°C, and final washes were at 65°C in 13 SSC, 0.1% SDS.
s of reproduction in any form reserved.
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127Vezf1 Expression during EmbryogenesisChromosomal Mapping
The Jackson Laboratory interspecies backcross panel (C57BL/
6Ei 3 SPRET/Ei)F1 3 SPRET/Ei, known as Jackson BSS (Rowe et al.,
994), was used to map the Vezf1 locus. Single-strand conformational
olymorphism (SSCP) between the two parental strains C57BL/6Ei
nd SPRET/Ei was detected by using a pair of primers that span an
ntron in the genomic DNA 39 of the retroviral insertion [PCR
rimers 59-GGA GGT GTT TGT ACA CAT GCT CTG-39 (Map 3A)
nd 59-GCT GTG GAT GGA GCA GAA TCC AGT-39 (Map 3B)].
riefly, a 25-ml PCR contained 50 ng DNA template, 13 PCR buffer,
0 mM dNTPs, 0.5 mM Mg21, 10 pmol each primer, 1 u Taq
olymerase (NEB), and 1.25 mCi [a-32P]dCTP. PCR cycles were 94°C
or 1 min, 55°C for 1 min, 72°C for 2 min, and 35 cycles. The PCR
roducts were melted and resolved on a 6% nondenaturing poly-
crylamide gel (Spinardi et al., 1991) for 3 h at 30 W constant power,
°C. Each sample was genotyped for the presence of the SPRET/Ei
llele and the results were transmitted back to the database of The
ackson Laboratory for comparison with the existing maps.
RESULTS
Retroviral Insertion in ES Cells into a
Developmentally Regulated Gene
ES cell clone 1-13 was identified in a genetic screen for
developmentally regulated genes in mouse ES cells, using
retroviral entrapment vectors with a human placental AP
reporter gene. Candidate genes were identified based upon
the patterns of reporter gene expression during in vitro
differentiation of ES cells into EBs and colocalization of AP
expression with that of lineage-specific markers (Leahy et
al., 1999; Xiong et al., 1998). One clone, 1-13, displayed
localized AP expression during EB formation but not as
undifferentiated ES cells (Fig. 1, and not shown) and has been
described previously. Spotty staining was detected in day 4
cultures of simple EBs, often located on the surface of
transparent yolk sac-like structures (Fig. 1A). Highest levels
of AP expression was observed in day 7 cystic EBs (Fig. 1B),
and reduced AP expression was found in day 10 EBs and in
day 6 cultures of reattached EBs (Figs. 1C and 1D). In
embryos derived from clone 1-13 ES cells, AP reporter gene
expression was detected in the developing vascular struc-
tures. AP expression in EBs and transgenic embryos largely
colocalized with in situ hybridization signal from the endo-
thelial cell lineage marker flk-1 (Leahy et al., 1999; Xiong et
l., 1998). Mice hetero- or homozygous for the 1-13 insertion
ere viable and fertile, and they did not show any overt
bnormalities during embryogenesis or as adults.
AP Reporter Gene Expression in Transgenic Line
1-13 Embryos
We examined in detail AP expression patterns in embryos
heterozygous for the 1-13 insertion between E7.25 and E11.5
by whole-mount AP staining (Fig. 2) and in histological
sections (Fig. 3). AP expression was first detected in whole-
mount embryos at the advanced primitive streak stage
d
p
Copyright © 1999 by Academic Press. All rightE7.25) as a ring-shaped stripe in the extraembryonic meso-
erm of the yolk sac (Fig. 2A). Sagittal and transverse
ections revealed that the AP signal was restricted to the
xtraembryonic mesoderm of the visceral yolk sac (Fig. 3a,
–D) and the anteriormost intraembryonic mesoderm of
he future “heart anlage,” located between the amnion and
he foregut indentation (Fig. 3a, A and B). No expression
as detected in the extraembryonic endoderm of the vis-
eral yolk sac, amnion, allantois, ectoplacental cone, or in
ther regions of the embryo proper (Fig. 3a, A). During
eural plate formation (E7.5), AP expression domains in
hole-mount stained embryos expanded throughout the
olk sac, became more diffuse, and extended into the
mbryo proper (Fig. 2B). In contrast to the expression
attern reported for flk-1 (Yamaguchi et al., 1993), AP
eporter gene expression was not observed in cells of the
ndocardial tubes (Fig. 2B). In parasagittal sections, AP
xpression was strongest in clusters of visceral mesoderm
ells of the yolk sac, which constitute the precursors of the
olk sac blood islands. AP expression was also detected
hroughout the visceral yolk sac mesoderm and, to a lesser
xtent, in the anterior region of the intraembryonic meso-
erm (Fig. 3a, E and F). In transverse sections of early
omite-stage embryos (E8.0), AP staining was found around
he dorsal aorta, in the endocardium, and in endothelial
ells lining the vascular plexus within the yolk sac blood
slands (Fig. 3a, G and H) and colocalized with the expres-
ion of flk-1 (Leahy et al., 1999; Xiong et al., 1998).
Stage E8.5 embryos that underwent the turning process
Fig. 2C) showed strong AP staining throughout the embryo
roper and the allantois and lesser staining in the yolk sac
embranes. Between E9.5 and E11.5, as embryonic vascu-
ogenesis and angiogenesis proceeded, AP expression per-
isted but decreased overall and became more clustered in
he vascular plexus of the cephalic mesenchyme, between
he somites, in the branchial arches and the limb buds, and
n the yolk sac membranes (Figs. 2D–2F, and not shown). In
ections of E8.0 to E9.5 embryos, AP expression localized to
ndothelial cells of the dorsal aorta and vitelline vein,
lusters of mesodermal cells in the head mesenchyme
presumably the angioblasts for the cephalic capillary
lexus), the endocardium, and the yolk sac blood islands
Fig. 3b, A–H). Between E8.5 and E9.5, AP expression in the
lood islands became restricted to the vascular endothelial
ells lining the perimeter of the blood island. At E9.5, no
xpression was detected in the innermost, spherical primi-
ive blood cells (Fig. 3b, compare D to H). AP expression at
9.5 coincided with the in situ hybridization signal of flk-1
Leahy et al., 1999).
In summary, the AP expression pattern detected in 1-13
ice and its overlapping expression with that of flk-1
uggested that the endogenous entrapped gene is expressed
uring development in vascular endothelial cells and their
recursors.
s of reproduction in any form reserved.
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129Vezf1 Expression during EmbryogenesisAnalysis of the Vector Insertion Site in Clone 1-13
ES cell clone 1-13 contains a single copy of the PT-
IRES-AP vector integrated in its genome (Fig. 4A,top; Xiong
et al., 1998). To understand on the molecular level the
entrapment vector insertion, we selectively cloned a 2.9-kb
EcoRI–EcoRI fragment containing 2.0 kb of the 39 portion of
proviral DNA and 0.9 kb of 39 flanking host genomic DNA
by supF complementation (Xiong et al., 1998). The se-
quence of flanking genomic DNA did not reveal any ho-
mologies with known sequences in the databases (not
shown). The flanking genomic sequence was specific for the
preintegration site of the PT-IRES-AP vector in clone 1-13,
as evident from Southern blot analysis of EcoRI-digested
DNA of parental R1 ES cells, clone 1-13 cells, wild-type
CD-1 mice, and mice hetero- and homozygous for the
vector insertion (Fig. 4A, bottom). A probe corresponding to
the 39 flanking sequences hybridized to an 8.0-kb endoge-
nous EcoRI fragment and to a 2.9-kb EcoRI fragment that
was specific for the vector insertion. Thus, DNA from 1-13
cells and heterozygous mice resulted in two fragments of
8.0 and 2.8 kb, whereas only the 2.9-kb fragment specific for
the 1-13 locus was present in DNA from homozygous mice.
VEZF1 Is the Murine Homologue of the Human
Transcription Factor DB1
The 0.9-kb genomic DNA fragment was used as a probe
to screen an E7.5 mouse embryo cDNA library. The two
longest overlapping cDNAs, clone 10-1 of 1429 bp length
and clone 10-2 of 1230 bp length, were isolated. The region
of sequence overlap corresponded to a putative noncoding
exon in the 39 flanking genomic DNA (not shown). cDNA
clone 10-1 shared significant homology to the 39 end of a
previously identified human gene, DB1. DB1 was originally
isolated in Jurkat T cells as a protein that specifically binds
to a GT/GC-rich region of the human interleukin-3 (IL-3)
promoter (Koyano-Nakagawa et al., 1994). The 59 portion of
the mouse cDNA was obtained by using RT-PCR with a 39
primer derived from clone 10-1 and a 59 primer correspond-
FIG. 3. AP reporter gene expression in histological sections of 1
tained as described in the legend to Fig. 2. AP-stained embryos we
ections of E7.25, E7.5, and E8.0 embryos. Parasagittal section of E7
ntra- and extraembryonic anterior region of the embryo (B); transv
C); higher magnification of C, showing extraembryonic visceral
igher magnification of E, showing extra- and intraembryonic re
agnification of yolk sac membrane shown in G (H). (b) Histologica
t the level of the heart (A); higher magnification of A, showing the
t the level of the heart (E); higher magnification of E, showin
bbreviations: all, allantois; am, amniotic membrane; atr, atria c
essels; cm, cephalic mesenchyme; cp, choroid plexus; da, dorsal
ndoderm; em, embryonic mesoderm; en, endocardium; ep, ecto
xm, extraembryonic mesoderm; fg, foregut; ht, heart; kid, kidney
ube; ov, otic vesicles; pc, pericardial cavity; pbc, primitive blood cells; s
ac; ysv, yolk sac vascular plexus.
Copyright © 1999 by Academic Press. All righting to the immediate 59 sequences of the human DB1 cDNA
(see Materials and Methods). A 3681-bp full-length coding
mouse cDNA was obtained by these two complementary
approaches and proved to be the previously unidentified
mouse homologue of human DB1 (Figs. 4B and 4C). Based
on its specific expression in the embryo (see below) and its
structural hallmarks, the mouse gene identified in our
screen was named Vezf1 for vascular endothelial zinc finger
1 (approved by the Mouse Nomenclature Committee, The
Jackson Laboratory).
An in-frame ATG initiation codon was found at position
40 within a Kozak consensus sequence (Kozak, 1987) and a
termination codon at position 1593. The 1554-bp coding
sequence of the cDNA is flanked at the 59 end by a typical
GC-rich sequence and at the 39 end by 2080 bp of untrans-
ated sequences that contained a consensus poly(A) signal
1 bp upstream of the poly(A) stretch. Alignment of the
enomic sequences at the entrapment vector insertion with
he endogenous cDNA sequence revealed that the insertion
n ES cell clone 1-13 had occurred in the 39 untranslated
egion of the gene (Fig. 4B). The Vezf1 cDNA encodes a
utative 518-amino-acid protein with a predicted molecular
ass of 56 kDa. The deduced amino acid sequence of
EZF1 was aligned and compared with the human DB1
equence (Koyano-Nakagawa et al., 1994). The two proteins
hare 98% overall sequence identity and 100% identity in
he region of zinc fingers 2 to 5, between amino acids 176
nd 308. Similar to the human DB1, the amino acid se-
uence for Vezf1 contains six zinc finger domains of the
ys2/His2-type (Fig. 4C, underlined), a glutamine stretch
Fig. 4C, asterisks), and periodically appearing proline resi-
ues in the C terminal 110 amino acids. The DB1 sequence
iffers from that of VEZF1 by the presence of 13 instead of
5 glutamine residues. Database searches revealed that
ouse Vezf1 shares 76% amino acid sequence identity over
the last five zinc fingers with Pur-1 (Kennedy and Rutter,
1992), but no significant homology outside the zinc finger
domains. Pur-1 is the mouse homologue to human MAZ
(ZF87), a Zn finger protein that binds to the c-Myc and CD4
ransgenic embryos. Transgenic embryos were isolated, fixed, and
stfixed and embedded with paraffin and sectioned. (a) Histological
mbryo and placental cone (A); higher magnification of A, showing
section of E7.25 embryo through extraembryonic visceral yolk sac
derm and endoderm (D); parasagittal section of E7.5 embryo (E);
of embryo (F); transverse section of E8.0 embryo (G); and high
tions of E8.5 and E9.5 embryos. Transverse sections of E8.5 embryo
fold (B); heart (C); yolk sac (D); transverse section of E9.5 embryo
e neural tube (F); heart atria (G); and yolk sac membrane (H).
er; bi, blood islands; br, brain; bra, branchial arch; cap, capillary
a; ec, endothelial cells; ee, embryonic ectoderm; een, embryonic
ental cone; epi, epithelial cells; exe, extraembryonic ectoderm;
liver; lun, lung; mn, meningeal plexus; nf, neural fold; nt, neural-13 t
re po
.25 e
erse
meso
gion
l sec
head
g th
hamb
aort
plac
; liv,
om, somites; uv, umbilical veins; ven, ventricle chamber; ys, yolk
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130 Xiong et al.FIG. 4. Molecular cloning of the 1-13 retroviral insertion site and Vezf1 cDNA. Proviral and flanking cellular sequences were isolated by
using the supF complementation method (Xiong et al., 1998). Vezf1 cDNA was isolated as described under Materials and Methods,
equenced, and analyzed using the Mac Vector program. (A) (Top) Schematic map of the 1-13 proviral integration site with the PT-IRES-AP
ector and flanking genomic DNA. The positions of the EcoRI (E) restriction sites used for supF cloning, and a KpnI restriction site in the
9LTR used for subcloning a 0.9-kb KpnI–EcoRI fragment, are indicated. (Bottom) Genomic Southern blot containing 10 mg each of
EcoRI-digested DNA from uninfected R1 ES cells, clone 1-13 cells, and tail from mice wild-type, homozygous, or heterozygous for the 1-13
insertion. l DNA digested with EcoRI and BamHI was included as a size marker. The filter was hybridized to the flanking 0.9-kb
a-32P]dCTP-labeled KpnI–EcoRI fragment. (B) Structure of Vezf1 cDNA. The position of the 1-13 retroviral insertion in the 39 untranslated
region and the positions of probes A, B, and C are indicated. (C) Nucleotide and deduced amino acid sequence of the Vezf1 cDNA. Zinc
finger motifs are underlined, and the glutamine stretch is indicated by asterisks. (D) Comparison of amino acid sequences of Vezf1 and
Pur-1, including zinc fingers 2–5 and the stretches of glutamine or alanine, respectively. Numbers denote the amino acid position from the
first in-frame Met.
Copyright © 1999 by Academic Press. All rights of reproduction in any form reserved.
FIG. 4—Continued
131
132 Xiong et al.
a
1
i
d
i
V
c
4
a
d
a
e
a
b
i
s
o
t
w
5
c
d
d
e
e
t
g
a
v
w
s
a
l
5
e
l
e
5
t
s
t
t
o
b
T
t
a
m
b
V
t
p
l
s
i
6
c
o
s
a
p
p
o
s
e
s
t
b
p
i
b
c
b
(
(
A
133Vezf1 Expression during Embryogenesispromoter (Bossone et al., 1992; Duncan et al., 1995; Pyrc et
l., 1992). Alignment of the Vezf1 amino acid sequence
68–360 with the corresponding Pur-1 sequence is shown
n Fig. 4D. No other genes were found in the available
atabases with significant homology to Vezf1.
Expression of Vezf1 during Embryogenesis Is
Restricted to the Endothelial Cells and Their
Precursors
To determine the temporal and spatial distribution of
Vezf1 during embryogenesis, standard RNA in situ hybrid-
zation was performed on sections of staged embryos. A
ezf1 antisense riboprobe corresponding to the 39 end of the
oding sequences and 39 untranslated region (probe C in Fig.
B) was highly specific for Vezf1 transcripts and was used in
ll subsequent in situ experiments. A sense control probe
id not show any nonspecific hybridization (Fig. 5F). Over-
ll, the patterns of endogenous Vezf1 and AP reporter gene
xpression in transgenic 1-13 embryos were indistinguish-
ble (compare Fig. 3 to Figs. 5 and 6).
Expression in mesodermal precursors of hemangio-
lasts. Onset of Vezf1 expression was detected at the
primitive streak stage (E7.25) and localized to the extraem-
bryonic mesodermal component of the visceral yolk sac. At
this stage, no condensation of mesodermal cells, indicative
of hemangioblasts in the primitive blood islands, could be
detected (Figs. 5A and 5B). Labeling of the mesodermal cells
was strong and uniform. No expression was found in the
ectoplacental cone, amnion, chorion, or regions of the em-
bryo proper.
Expression during early vasculogenesis. Transverse
sections of E8.5 embryos showed intensely labeled patches
of Vezf1 expression in regions of angioblast differentiation
nto the primary vascular plexus (Figs. 5C and 5D). Thus,
trong Vezf1 expression was detected in capillary structures
f the cephalic mesenchyme and the first branchial arch,
he inner lining of the dorsal aorta and its communication
ith the first branchial arch artery, the endocardium (Fig.
C), and the yolk sac blood islands, and it was found to
olocalize with flk-1 expression (Xiong et al., 1998).
Expression during angiogenesis. In embryos between
ays 10.5 and 13.5 of gestation, Vezf1 expression was
etected in vascular structures arising by both vasculogen-
sis and angiogenesis. In parasagittal sections of E10.5
mbryos, high levels of Vezf1 expression were detected in
FIG. 5. RNA in situ hybridization analysis of Vezf1 mRNA in s
solated, embedded in paraffin, and sectioned. Transgenic embryos
efore embedding. Sections were processed for RNA in situ hybridiz
ontrol probe (F). (A and B) Dark-field (A) or bright-field (B) view o
right-field (D) view of a transverse section of E8.5 through the hear
G and H) High-power magnification of dorsal aorta, (K and L) arter
M and N) vessels in branchial arch in E. (O and P) Bright-field, high-p
bbreviations are the same as in Fig. 3.
Copyright © 1999 by Academic Press. All righthe putative angioblasts of the head mesenchyme, menin-
eal plexus surrounding the brain and spinal cord, dorsal
orta, heart chambers, truncus arteriosus, and umbilical
ein (Fig. 5E, and not shown). In addition, strong expression
as detected in capillaries sprouting from the dorsal aorta,
uch as the intersomitic vessels and vessels in the branchial
rches, as well as in sprouting capillaries in the lung and
iver rudiments and in the mesonephros (Figs. 5E, 5G, 5I,
K, 5M, 5O, and 5P). Higher magnification revealed that
xpression of Vezf1 appeared to be restricted to a single cell
ayer of presumptive endothelium in the larger vessels, the
ndocardium, and the intersomitic vessels (Figs. 5G, 5I, and
K). Furthermore, expression in kidney and lung was de-
ected only as small patches in what appeared to be inter-
titial capillaries between mesenchymal cells, but not in
he epithelium (Figs. 5O and 5P).
Sustained expression of Vezf1 was detected at E13.5
hroughout the vascular plexus (Figs. 6A and 6E). Due to
ngoing sprouting of new capillaries throughout the em-
ryo, the vascular system is more complex than at E10.5.
his was reflected in the punctate expression of Vezf1 in all
issues in which extensive angiogenesis occurs. For ex-
mple, clusters of Vezf1-expressing cells were present in the
esenchyme of the choroid plexus, suggesting points of
ranching and sprouting of new vessels (Fig. 6C). Punctate
ezf1 expression was also found throughout the CNS and in
he craniofacial mesenchyme (Figs. 6A and 6E). High ex-
ression was detected in capillaries of the kidney, liver, and
ung (Figs. 6B, 6D, and 6G). Vezf1 expression was also
trong in the dorsal aorta and surrounding capillaries, in
ntervertebrae vessels, and in the heart ventricle (Figs. 6B,
F, and 6H). At later stages of embryogenesis (E16.5),
ontinued but overall reduced expression of Vezf1 was
bserved throughout the vascular system. Highest expres-
ion in late-stage embryos was detected in the capillaries
nd lower expression in the large vessels (not shown).
Absence of Vezf1 expression during embryonic hemato-
oiesis. No Vezf1 expression could be detected in the
rimitive hematopoietic cells of the yolk sac blood islands
r in circulating nucleated blood cells that were trapped in
ections of the dorsal aorta and heart at any time during
mbryogenesis (Figs. 5G, 6H, 6I, 6J, and 6F, and data not
hown). Vezf1 signal in fetal liver appeared to be restricted
o interstitial capillaries, and no unambiguous signal could
e detected under high magnification on primitive hemato-
oietic cells of E13.5 fetal liver (Fig. 6D, and not shown).
mouse embryos. Wild-type or 1-13 heterozygous embryos were
stained as whole mounts with BM purple (Boehringer Mannheim)
n, using an antisense Vezf1 riboprobe (probe C in Fig. 4B) or a sense
rasagittal section of an E7.25 embryo. (C and D) Dark-field (C) or
and F) Dark-field view of a parasagittal section of an E10.5 embryo.
rrounding the somites and (I and J) endocardium of the heart, andtaged
were
atio
f a pa
t. (E
ies suower magnification of lung (O) and of kidney (P) rudiments in E.
s of reproduction in any form reserved.
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134 Xiong et al.FIG. 6. RNA in situ hybridization analysis of Vezf1 mRNA in E13.5 mouse embryos. Wild-type embryos were isolated, embedded in paraffin,
and sectioned. Sections were processed for RNA in situ hybridization, using an antisense Vezf1 riboprobe (probe C in Fig. 4B). (A and E) Dark-field
iew of parasagittal sections of E13.5 embryos. (B) Higher magnification of A showing blood vessels between somites and around epithelial cells
f nephron (kid), (C) choroid plexus (cp) of the forth ventricle, and (D) liver (liv). (F) Higher magnification of E showing dorsal aorta (da), (G) blood
essels around lung epithelium, and (H) endocardium and blood vessels of the ventricle. Abbreviations are the same as in Fig. 3.
Copyright © 1999 by Academic Press. All rights of reproduction in any form reserved.
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135Vezf1 Expression during EmbryogenesisExpression of Pur-1 in embryos is widespread. We
FIG. 7. Expression of Vezf1 in embryos, adult organs, and establi
hybridized with an [a-32P]dCTP-labeled Vezf1 fragment as describe
were rehybridized with an [a-32P]dCTP-labeled mouse GAPDH pl
embryos. (B) RNAs from adult organs of CD-1 mice. KID, kidney;
brain; OVA, ovary; UTE2, UTE16, uterus from a mouse at day 2 or
FL, fetal liver from a E16.5 embryo; PLAC, placenta from a E1
hemangioendothelioma line; C165, C166, and C167, murine yol
endothelial cells. (D) RNAs from murine hematopoietic cell lines
4T-31; MEL, erythroleukemia cells; MACRO1, macrophage cell lincompared the developmental expression of Vezf1 with that
of Pur-1, a mouse gene that shares 76% homology with
t
m
Copyright © 1999 by Academic Press. All rightezf1 in its zinc finger coding region (see above). Pur-1
1
cell lines. 20 mg each of total RNA was resolved, transferred, and
der Materials and Methods. After removal of the probe, the filters
d. (A) RNAs from ES cells, ES cell-derived EBs, and staged CD-1
, gut; MUS, muscle; LUN, lung; HRT, heart; THY, thymus; BR,
16 of pregnancy, respectively; TES, testes; E16.5, day 16.5 embryo;
embryo. (C) RNAs from endothelial cell lines. EOMA, murine
-derived endothelial cell lines; HUVEC, human umbilical vein
ES cell line; B, pre-B cell line L1.2; T, T cell hybridoma cell line
16 (resting); MACRO2, macrophage cell line PW16 (proliferating).shed
d un
asmi
GUT
day-
6.5
k-sacranscripts were previously found in poly(A) RNA from
ouse embryos between day 7 and day 17 of gestation
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136 Xiong et al.(Tsutsui et al., 1996). Strong, widespread expression was
etected throughout E10.5 and E12.5 embryos with a Pur-
-specific antisense probe, but not with a sense control
robe (data not shown). Highest expression was detected at
10.5 in the neuroepithelium of the mesencephalon, the
NS, and the somites, and lower expression was found in
he heart.
Vezf1 Transcripts Are Present in Adult Tissues
and in Endothelial and Hematopoietic Cell Lines
To determine the distribution and size of Vezf1 tran-
cripts, Northern blot analysis was performed on total RNA
rom embryoid bodies, staged embryos between E8.5 and
16.5, adult organs, and established cell lines (Fig. 7). A
ajor Vezf1-specific transcript of 4.2 kb and a lower abun-
ance 1.7-kb transcript were detected in all sources of RNA
y using a 59 Vezf1 cDNA probe (probe A in Fig. 4B).
Elevated levels of Vezf1 expression were found in embryoid
odies between day 3 and day 10 in suspension culture and
uring embryogenesis around E10.5 (Figs. 7A and 7B),
onsistent with the intensity of the in situ hybridization
signals observed. In adult CD-1 mice, a high-abundance
Vezf1 transcript of about 4.5 kb in length was observed in
several somatic tissues and in the gonads in addition to the
4.2- and 1.7-kb transcripts (Fig. 7B). The relative abundance
of the two major transcripts, 4.5 and 4.2 kb in size, differed
among the organs, with muscle, heart, thymus, brain, and
ovaries showing similar amounts of both transcripts. High-
est overall levels of Vezf1 expression were found in lung,
heart, thymus, ovaries, and placenta, presumably reflecting
FIG. 8. Southern zoo blot analysis of genomic DNA from different
pecies was digested with BamHI (B), EcoRI (R), or HindIII (H), reso
ybridized to an [a-32P]dCTP-labeled Vezf1 fragment (probe B in Fig
exposed for 1 day (DNA from chicken, mouse, human) and 4 daysthe relative contribution of endothelial cells to these or-
gans. In addition, Vezf1 transcripts were found in fetal liver
w
a
Copyright © 1999 by Academic Press. All rightand placenta from embryos at day 16.5 of gestation and in
uterus from pregnant females at day 2 and day 16 of
gestation (Fig. 7B).
High levels of the 4.2-kb transcript were also found in a
mouse hemangioendothelioma-derived cell line EOMA
(Obeso et al., 1990) and in various endothelial cell lines
derived from mouse E12 yolk sacs (Wang et al., 1996) (Fig.
7C). The mouse Vezf1 probe also cross-hybridized with two
transcripts in human umbilical vein endothelial cells (Fig.
7C), corresponding in size to DB1 transcripts reported in
Jurkat T cells (Koyano-Nakagawa et al., 1994). Consistent
with the expression of its human homologue DB1, Vezf1
transcripts were also detected in several established murine
hematopoietic cell lines, albeit at reduced levels compared
to endothelial cell lines (Fig. 7D). Vezf1 expression was
higher in a pre-B cell and a T cell hybridoma line than in
mouse erythroleukemia cells or a macrophage line (Fig. 7D).
The major Vezf1 transcript of about 4.2 kb that was present
in all sources of RNA was larger than the 3.68-kb cDNA
that we isolated. This discrepancy in size could be ex-
plained by additional 59 untranslated sequences in the
endogenous Vezf1 transcript.
Vezf1-Related Sequences in Vertebrates and
Invertebrates
Zoo blot analysis was used to determine whether Vezf1-
related genes were present in other vertebrate and inverte-
brate species. Genomic DNA from yeast, Caenorhabditis
elegans, Aplysia, earth worm, Drosophila, sea urchin, ze-
rafish, Xenopus, Gallus, mouse, and human was digested
rtebrate and vertebrate species. 20 mg genomic DNA from different
n 0.8% agarose gels, transferred to nitrocellulose membranes, and
(Materials and Methods). The figure is a composite of X-ray films
A from sea urchin, zebrafish, Xenopus, and invertebrates).inve
lved o
. 4B)ith BamHI, EcoRI, or HindIII, resolved on agarose gels,
nd transferred to nitrocellulose membranes. The filters
s of reproduction in any form reserved.
cc
c
t
i
r
137Vezf1 Expression during Embryogenesiswere hybridized at reduced stringency with a 39 Vezf1
DNA fragment containing the last 3 12 zinc finger domains
(probe B in Fig. 4B) and washed at high stringency (Materials
and Methods). Two strong hybridizing bands and additional
bands with reduced intensity were detected in the genomic
DNA from chicken, mouse, and human (Fig. 8). Reprobing
of the Southern zoo blot with 59 cDNA fragments specific
for Vezf1 or Pur-1 indicated that most if not all of the bands
detected in Fig. 8 corresponded to endogenous Vezf1 or
Pur-1 sequences (data not shown). These results suggest
that Vezf1 is a member of a small family of related zinc
finger genes. Surprisingly, only weak hybridization signals
were detected in DNA from amphibia and fish, similar to
results obtained with DNA from several invertebrate spe-
cies. Upon longer exposure, discrete hybridizing fragments
were detected in DNA from Xenopus, zebrafish, sea urchin,
and Drosophila (Fig. 8). These results suggest that Vezf1
sequences are highly conserved only among higher verte-
brates that form extraembryonic membranes, consistent
with the hypothetical evolution of this gene concomitant
with the appearance of the yolk sac membrane in species
such as reptiles and birds that lay their eggs on land.
Chromosomal Mapping of the Vezf1 Locus
A DNA interspecies backcross panel from The Jackson
Laboratory community resource, Jackson BSS [(C57BL/
6Ei 3 SPRET/Ei)F1 3 SPRET/Ei] (Rowe et al., 1994) was
used to map the chromosomal position of the Vezf1 locus.
A SSCP between the two parental strains was detected by
using PCR primers that span intronic sequences in the
flanking genomic DNA (Materials and Methods). Analysis
of the backcross panel data placed the Vezf1 locus onto the
proximal end of mouse Chromosome 2 (Fig. 9). Vezf1
cosegregated with six known genes, collagen pro-a1 (V)
hain (Col5a1), dopamine b-hydroxylase (Dbh), a Lim-
ontaining homeoprotein (Lhx3), the mouse homologue of
he Drosophila notch gene (Notch1), retinoid receptor a
subunit (Rxra), brain a spectrin (Spna2), and several other
markers. Nine loci mapped one crossover distal to the Vezf1
locus, including the Abelson proto-oncogene (Abl), endog-
lin (Eng), and the proto-oncogene homeobox gene Pbx3.
This region of mouse Chromosome 2 has extensive homol-
ogy to human Chromosome 9q (Pilz et al., 1992), a region
which contains several loci that are associated with human
genetic disorders. For example, Eng is the gene for heredi-
tary hemorrhagic telangiectasia type 1, an autosomal domi-
nant vascular dysplasia (McAllister et al., 1994).
DISCUSSION
We have cloned and characterized a “promoter trap”
vector insertion into a novel endothelial-specific zinc finger
gene, Vezf1. The insertion was identified in a genetic screen
n ES cells by virtue of its restricted expression of the AP
eporter gene, and the colocalization of AP and flk-1 expres-
Copyright © 1999 by Academic Press. All rightFIG. 9. Chromosomal mapping of the Vezf1 gene. The Jackson BSS
backcross panel was used to map the Vezf1 locus as described under
Material and Methods. (A) Haplotype figure from the Jackson BSS
backcross showing part of Chromosome 2 with loci linked to Vezf1.
Loci are listed in order with the most proximal at the top. The black
boxes represent the C57BL6/JEi allele and the white boxes the
SPRET/Ei allele. The number of animals with each haplotype is given
at the bottom of each column of boxes. The percentage recombination
(R) between adjacent loci is given to the right, with the standard error
(SE) for each R. Missing typing were inferred from surrounding data
where assignment was unambiguous. (B) Map figure from the Jackson
BSS backcross showing the proximal end of Chromosome 2. The map
is depicted with the centromere toward the top. A 5-cM scale bar is
shown to the right. Loci mapping to the same position are listed in
alphabetical order. Missing typing were inferred from surrounding
data where assignment was unambiguous. Raw data from The Jack-
son Laboratory can be obtained from the World Wide Web address
http://www.jax.org/resources/documents/cmdata.
s of reproduction in any form reserved.
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138 Xiong et al.sion in embryoid bodies and embryos (Leahy et al., 1999;
Xiong et al., 1998). Detailed examination of staged embryos
y in situ hybridization and histochemical AP staining
evealed that Vezf1 expression was restricted to vascular
ndothelial cells and their precursors in the developing
mbryo.
Its expression pattern is consistent with Vezf1 specifi-
ally marking the earliest bipotential progenitors of the
ndothelial and embryonic hematopoietic lineage, the he-
angioblasts, as well as endothelial cells arising during
oth vasculogenesis and angiogenesis. Thus, its early onset
nd restricted expression suggests a primary role for Vezf1
n the determination of mesodermal cells to the hemangio-
last and endothelial lineage and a later role in the devel-
pment of the vascular plexus. Recent studies have pro-
ided direct evidence for the existence of the long
ypothesized hemangioblast (Choi et al., 1998; Kennedy et
l., 1997; Shalaby et al., 1997). To this point, our analysis of
ezf1 expression in the yolk sac does not allow us to
etermine if expression is restricted to the presumptive
emangioblasts and angioblast progenitors, in addition to
he endothelial lineage. Alternatively, Vezf1 might already
e expressed in mesodermal cells before they become com-
itted to hemangioblasts. In addition, it is possible that
ezf1 is expressed transiently in early hematopoietic cells
f the blood islands. Examination of the differentiation
otential of AP-expressing cells in embryoid bodies, similar
o studies performed by Choi et al. (1998), should distin-
uish between these possibilities.
The overall expression patterns of Vezf1 and the receptor
yrosine kinase flk-1 (Millauer et al., 1993; Yamaguchi et
l., 1993) are very similar. In fact, expression of both genes
s first detected in the presumptive hemangioblasts of the
lood islands. Furthermore, Vezf1 and flk-1 were found to
colocalize to the same cells during embryoid body differen-
tiation and in embryos (Leahy et al., 1999; Xiong et al.,
1998). However, a few important differences should be
noted. First, Vezf1 expression in primitive streak-stage
embryos was confined and uniformly strong in apparently
all cells of the extraembryonic yolk sac mesoderm and a
small group of presumptive angioblasts that form the endo-
cardium. In contrast, flk-1 displayed a more widespread and
diffuse expression throughout the yolk sac and in the
proximal-lateral embryonic mesoderm. Furthermore, in
contrast to flk-1 (Matthews et al., 1991; Yamaguchi et al.,
1993), no specific Vezf1 expression was detected in the
endocardial tubes or in primitive hematopoietic cells
within the fetal liver. Embryos homozygous for a flk-1 null
allele die at midsomite stage due to the failure to form yolk
sac blood islands (Shalaby et al., 1995). Analysis of the
developmental potential of flk-12/2 ES cells in chimeric
mbryos demonstrated that flk-1 is required for hematopoi-
sis, vasculogenesis, and possibly the movement of meso-
ermal precursor cells into the yolk sac (Shalaby et al.,
997). It will be important to examine if the similarity in
he expression patterns of Vezf1 and flk-1 reflects also a
imilar role for both during development.
Z
A
Copyright © 1999 by Academic Press. All rightUsing Northern analysis, we showed that Vezf1 tran-
cripts are present in all embryonic and adult organs tested.
hese results are in agreement with the previously reported
idespread expression of its human homologue, DB1
Koyano-Nakagawa et al., 1994). We believe that the Vezf1
ranscripts reflect the contribution of vascular endothelial
ells to these tissues. Our preliminary RNA in situ studies
ndicate that Vezf1 expression in adult organs remains
verall specific for the vascular endothelial cells. Addition-
lly, low level of expression was detected in adult bone
arrow, but not in peripheral blood or the hematopoietic
ells of the spleen or thymus (A. Leahy, J.-W. Xiong, and H.
tuhlmann, manuscript in preparation). Furthermore, in
ddition to endothelial cell lines, we also detected Vezf1-
pecific transcripts in established adult hematopoietic
ines. Because Vezf1 expression could not be detected in the
olk sac, fetal liver, or peripheral blood of embryos, this
ight indicate a secondary site of expression during adult
ematopoiesis. It is of interest to note that the human DB1
rotein was originally identified in human Jurkat T cells as
DNA binding activity to the IL-3 promoter (Koyano-
akagawa et al., 1994).
Molecular cloning of the Vezf1 cDNA provided addi-
ional clues about its potential function. Its deduced amino
cid sequence shows several hallmarks characteristic of
ranscription factors, including six zinc fingers of the Cys2/
is2-type and a glutamine-stretch and proline-rich region
hat are often found in transcriptional activation or repres-
ion domains. In support of the notion that Vezf1 encodes a
utative zinc finger transcription factor, we have identified
potential transactivation domain at the C-terminus of the
EZF1 protein (H. Stuhlmann, unpublished results). To
ate, nothing is known about potential binding sites for
EZF1 or candidate target genes that are regulated by
EZF1. It will be important to determine if any of the
nown endothelial-specific genes, including the receptor
yrosine kinases flk-1, flt-1, tie1, and tie2 are regulated by
EZF1. Interestingly, no in vivo target genes have been
dentified for its human homologue, DB1, either. Although
B1 was isolated by virtue of its specific binding to a
T/GC-rich region of the IL-3 promoter, no transcriptional
ctivation of the promoter was detected (Koyano-Nakagawa
t al., 1994).
Comparison of the Vezf1 cDNA and deduced protein
equences with available sequences in the databases, to-
ether with zoo blot Southern analysis, indicated that Vezf1
s a member of a small subfamily of zinc finger genes that
re highly conserved in higher vertebrate species. The only
ther known member of this family is Pur-1 (Kennedy and
utter, 1992), the mouse homologue of the human Myc-
ssociated transcription factor MAZ (Bossone et al., 1992;
uncan et al., 1995). Our RNA in situ analysis shows that
ur-1, in contrast to Vezf1, displays widespread expression
n developing embryos. No significant homology was de-
ected between Vezf1 and sequences from members of the
n finger erythroid Kru¨ppel-like factor multigene family.
t least one member of this family, LKLF, was recently
s of reproduction in any form reserved.
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139Vezf1 Expression during Embryogenesisshown to be required for blood vessel stabilization, al-
though its expression is not restricted to vascular endothe-
lial cells (Kuo et al., 1997). To our knowledge, Vezf1 is the
rst gene encoding a putative transcription factor identified
hose expression is completely restricted to vascular endo-
helial cells and its precursors in the developing embryo.
ther endothelial-expressed transcription factors, includ-
ng ARNT (Maltepe et al., 1997), HIF1a (Iyer et al., 1998),
SCL/tal1 (Visvander et al., 1998), LKLF (Kuo et al., 1997),
and Hex (Thomas et al., 1998), show a more widespread
expression pattern in embryos.
The entrapment vector used in this screen, PT-IRES-AP,
contained an internal ribosomal entry site from the en-
cephalomyocarditis virus upstream of the promoter-less AP
reporter gene, thus allowing AP translation independent of
an in-frame insertion into coding sequences of the endoge-
nous gene (Xiong et al., 1998). Consistent with the vector
insertion into genomic Vezf1 sequences corresponding to a
39 untranslated exon, no mutant phenotype was detected in
transgenic embryos or adult mice derived from the ES cell
clone. Expression of the knocked-in AP reporter gene in
embryos faithfully reflected the endothelial-specific expres-
sion of the endogenous Vezf1 mRNA. Thus, the transgenic
line should prove useful in the future as a source for
histochemically marking cells of the endothelial lineage.
It is tempting to hypothesize that Vezf1 plays a role in
nuclear transcriptional pathways that are regulated by
VEGF/flk-1 and/or flt-1 signaling. Alternatively, Vezf1
might respond to hemangioblast- or angioblast-inducing
factors like bFGF or BMP2/4 originating in the extraembry-
onic endoderm and might function as a transcriptional
regulator of flk-1 and/or flt-1. A third possibility is that
Vezf1 might act in a different, yet unidentified genetic
pathway that governs the differentiation of putative heman-
gioblasts into angioblasts and hematopoietic precursors, the
differentiation of angioblasts into endothelial cells, or the
movement of angioblasts to their site of differentiation. For
example, Vezf1 might be involved in regulating the secre-
tion of growth factors and morphogens or the expression of
cell surface or extracellular matrix proteins. To this point,
the nature of specific nuclear factors involved in these
pathways remains virtually unknown.
In summary, we have identified Vezf1 as a novel
endothelial-specific marker that encodes a putative zinc
finger transcription factor. Its early and overlapping expres-
sion with flk-1 and its highly restricted expression during
development suggest an important role for Vezf1 in the
development and differentiation of the vascular system.
Future studies, using gain-of-function and loss-of-function
approaches in mice, will be necessary to establish the exact
role of Vezf1 in development.
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